NasdaqGM - Nasdaq Real Time Price USD

Keros Therapeutics, Inc. (KROS)

Compare
14.56
-0.33
(-2.22%)
At close: January 10 at 4:00:01 PM EST
14.50
-0.06
(-0.41%)
After hours: 7:19:17 PM EST
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
370,025.00
306,781.00
255,251.00
269,443.00
Total Liabilities Net Minority Interest
37,812.00
29,358.00
12,077.00
7,722.00
Total Equity Gross Minority Interest
332,213.00
277,423.00
243,174.00
261,721.00
Total Capitalization
332,213.00
277,423.00
243,174.00
261,721.00
Common Stock Equity
332,213.00
277,423.00
243,174.00
261,721.00
Capital Lease Obligations
14,444.00
13,266.00
1,093.00
899.00
Net Tangible Assets
332,213.00
277,423.00
243,174.00
261,721.00
Working Capital
322,920.00
269,220.00
239,594.00
260,542.00
Invested Capital
332,213.00
277,423.00
243,174.00
261,721.00
Tangible Book Value
332,213.00
277,423.00
243,174.00
261,721.00
Total Debt
14,444.00
13,266.00
1,093.00
899.00
Share Issued
31,841.08
27,543.45
23,974.83
23,192.87
Ordinary Shares Number
31,841.08
27,543.45
23,974.83
23,192.87
12/31/2020 - 4/8/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers